
About Ogene Systems India Limited
Data last updated:
Ogene Systems India Limited was a public limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Swain Finance And Trading Private Limited. The company has been dissolved under section 54 as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 September 2004.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72200TG2004PLC044250. Its GSTIN is 36AAACO7056R1ZS (Telangana). The company held 3 GST registrations, of which 1 is active.
The company had an authorised share capital of ₹25 Cr and a paid-up capital of ₹24.93 Cr. It was formerly known as Ogene Systems India Private Limited. It was led by directors including Rayaprolu Prabhakar Sreenivas and Krishna Reddy Bellanagari.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at H.No.8 – 3 – 191 – 14 Housing Board No.5/A Vengal Rao Nagar, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.73 Cr, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹1.24 Cr (net margin -33.4%) and EBITDA of -₹1.22 Cr (EBITDA margin -32.6%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 41% over five years.
The company had about 13 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Ogene. As per MCA filings, the company had satisfied charges of ₹85.73 Cr on record. Court records list 12 cases involving the company, including 2 filed by the company and 10 filed against it.
The last known website on record is ogene.co.in.
Company details
CIN history
Ogene Systems India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U72200TG2004PLC044250, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200TG2004PLC044250 | Current |
| U72200AP2004PLC044250 | Previous |
| U72200AP2004PTC044250 | Previous |
Contact details
Ogene Systems India Limited's registered office is in Hyderabad, Telangana. Its website is ogene.co.in. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressH.No.8 – 3 – 191 – 14 Housing Board No.5/A Vengal Rao Nagar, Hyderabad, Telangana, India – 500038
- IndustryPharma, API Manufacturers
To see the full contact details of Ogene Systems India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ogene Systems India operates one associated brand: Ogene. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides contract research and development services in nanomedicine and radiolabeled products. | ogene.co.in |
Business activity
The main business activity of Ogene Systems India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ogene Systems India Limited, buy the company report.
Financials of Ogene Systems India Limited
FY 2020 filings availableOgene Systems India Limited reported revenue of ₹3.73 Cr (down 94% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 94% fall in the latest year. EBITDA fell 104% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹3.73 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -32.6% | ||||
| Net Profit Margin | -33.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ogene Systems India Limited, buy the company report.
Board of directors of Ogene Systems India Limited
Ogene Systems India has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rayaprolu Prabhakar Sreenivas | Additional Director | 24 Jul 2020 | 6 Years 3 Months | As last reported |
| Krishna Reddy Bellanagari | Additional Director | 04 Nov 2019 | 7 Years 0 Months | As last reported |
| Narsimulu Karka Also directs: Picsell Realtors LLP, Indus Housing Private Limited, Zeva Engineering and Management Services Private Limited and 1 more | Additional Director | 18 Mar 2021 | 5 Years 8 Months | As last reported |
Peer comparison
Ogene Systems India Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sam Laboratories Private Limited | ₹3.85 Cr (FY 2025) | -10.0% | Bhavnagar, Gujarat, India | |||
| Bizotic Lifescience Private Limited | ₹3.81 Cr (FY 2024) | -72.0% | New Kharachiya, Gujarat, India | |||
| Shanti Drugs Private Limited | ₹3.78 Cr (FY 2024) | 11.0% | New Delhi, Delhi, India | |||
| Ogene Systems India Limitedthis company | ₹3.73 Cr (FY 2020) | -₹1.24 Cr | -33.4% | -94.0% | 13 | Hyderabad, Telangana, India |
| Agati Healthcare Private Limited | ₹3.73 Cr (FY 2024) | 172.0% | Navi Mumbai, Maharashtra, India | |||
| Chorus Pharmachem Private Limited | ₹3.72 Cr (FY 2024) | -64.0% | Nandesari, Gujarat, India | |||
| Athene Chemicals Private Limited | ₹3.72 Cr (FY 2025) | -10.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Ogene Systems India Limited, buy the company report.
Auditor
Ogene Systems India Limited is audited by M G R & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M G R & CO | FY 2020 | 012787S |
Shareholding
The shareholding of Ogene Systems India Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ogene Systems India Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jul 2015 | 10585215 | State Bank of Travancore | ₹3.75 Cr | Satisfied | |
| 31 May 2014 | 10502327 | Reliance Capital Ltd | ₹3.2 Cr | Satisfied | |
| 31 May 2010 | 10225844 | State Bank of Travancore | ₹11.5 Cr | Satisfied | |
| 26 May 2010 | 10221753 | Technology Development Board | ₹13.5 Cr | Satisfied | |
| 05 Apr 2010 | 10214766 | State Bank of Hyderabad | ₹51.78 Cr | Satisfied |
To see the full charge records of Ogene Systems India Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Ogene Systems India Limited has 12 court cases on record: 2 filed by Ogene Systems India, 10 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 0 |
| High courts | 4 | 2 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Insolvency matter | Filed against the company by Platina Properties and Projects Limited | Disposed |
| High Court of Delhi | Arbitration matter | Filed against the company by National Research Development Corporation | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed against the company by Multichem Specialities Pvt Ltd | Disposed |
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed against the company by Ms. Reliance Capital Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Ms. R.R. Innovative Pvt. Ltd. | Disposed |
To see the full case history of Ogene Systems India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ogene Systems India Limited was last rated by Indiarating on 13 Jul 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 13 Jul 2018 |
To see the full credit ratings and regulatory alerts of Ogene Systems India Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ogene Systems India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ogene Systems India Limited has a workforce of 13 employees on its EPFO records as of Apr 2018, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2018-19 | 13 |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Ogene Systems India Limited, buy the company report.
GST
Ogene Systems India has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACO7056R1ZS | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ogene Systems India Limited, buy the company report.
Recent activity
Ogene Systems India Limited has 16 board changes on record since 2008: 3 appointments and 13 cessations. The latest: Narsimulu Karka was appointed as Additional Director on 18 Mar 2021.
21 earlier events are in the company report.
Frequently asked questions
Ogene Systems India has been "Dissolved Under Section 54" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Ogene Systems India was a public limited company based in Hyderabad, Telangana, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 23 September 2004 and is registered under CIN U72200TG2004PLC044250. The company is recorded as dissolved under section 54 in MCA records and no longer exists as a legal entity.
Ogene Systems India was incorporated on 23 September 2004. It is registered with the Registrar of Companies, Hyderabad.
Ogene Systems India had 3 directors:
- Rayaprolu Prabhakar Sreenivas - Additional Director
- Krishna Reddy Bellanagari - Additional Director
- Narsimulu Karka - Additional Director
The CIN (Corporate Identification Number) of Ogene Systems India is U72200TG2004PLC044250. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ogene Systems India is at H.No.8 – 3 – 191 – 14 Housing Board No.5A Vengal Rao Nagar, Hyderabad, Telangana, India – 500038.
Ogene Systems India can be reached through the website ogene.co.in. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Ogene Systems India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Ogene Systems India is 36AAACO7056R1ZS, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
Ogene Systems India operated in the pharma industry, in the api manufacturers segment.
The peers of Ogene Systems India by revenue are Sam Laboratories Private Limited, Bizotic Lifescience Private Limited, Shanti Drugs Private Limited, Agati Healthcare Private Limited, Chorus Pharmachem Private Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

